SCI Pharmtech Inc banner
S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 52.7 TWD 0.76% Market Closed
Market Cap: NT$6.3B

Wall Street
Price Targets

Price Targets Summary
SCI Pharmtech Inc

There are no price targets for SCI Pharmtech Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
SCI Pharmtech Inc Competitors:
Price Targets
PACB
Pacific Biosciences of California Inc
82% Upside
PLRX
Pliant Therapeutics Inc
132% Upside

Revenue
Forecast

2% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
2% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

For the last 14 years the compound annual growth rate for SCI Pharmtech Inc's revenue is 2%.

Operating Income
Forecast

-1% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
-1% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 14 years the compound annual growth rate for SCI Pharmtech Inc's operating income is -1%.

Net Income
Forecast

1% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-18%
Average Miss
1% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-18%
Average Miss

For the last 14 years the compound annual growth rate for SCI Pharmtech Inc's net income is 1%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SCI Pharmtech Inc's stock price target?
Not Available

SCI Pharmtech Inc doesn't have any price targets made by Wall Street professionals.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett